3 results
Approved WMORecruiting
To assess the effects and the cost effectiveness of self monitoring of glucose in DM2 patients who are not using insulin on diabetes related distress, glycaemic control and changes in behavioural determinants.
Approved WMOCompleted
(1) To asses the influence of P-gp function at the BBB on flumazenil binding to the GABAA-receptor in pharmacoresistant patients with temporal lobe epilepsy (TLE), using PET and [11C]flumazenil as a ligand and tariquidar as P-gp blocker. (2) If we…
Approved WMOCompleted
To determine appropriate dosing regimens for use in future clinical trials of GS 9820 in subjects with lymphoid malignancies.